Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives.
Journal
The European respiratory journal
ISSN: 1399-3003
Titre abrégé: Eur Respir J
Pays: England
ID NLM: 8803460
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
04
10
2018
accepted:
08
10
2018
pubmed:
14
12
2018
medline:
2
10
2020
entrez:
15
12
2018
Statut:
epublish
Résumé
Clinical and translational research has played a major role in advancing our understanding of pulmonary hypertension (PH), including pulmonary arterial hypertension and other forms of PH with severe vascular remodelling (
Identifiants
pubmed: 30545970
pii: 13993003.01887-2018
doi: 10.1183/13993003.01887-2018
pmc: PMC6351340
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NHLBI NIH HHS
ID : R01 HL138473
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL074186
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL014985
Pays : United States
Organisme : NHLBI NIH HHS
ID : P01 HL108797
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL122887
Pays : United States
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright ©ERS 2019.
Déclaration de conflit d'intérêts
Conflict of interest: M. Humbert reports personal fees from Actelion and Merck, and grants and personal fees from Bayer and GSK, outside the submitted work. Conflict of interest: C. Guignabert has nothing to disclose. Conflict of interest: S. Bonnet has nothing to disclose. Conflict of interest: P. Dorfmüller reports personal fees from MSD, Bayer, Actelion and Roche, outside the submitted work. Conflict of interest: J.R. Klinger reports grants for animal study of extra cellular vesicles from United Therapeutics, outside the submitted work. Conflict of interest: M.R. Nicolls has nothing to disclose. Conflict of interest: A.J. Olschewski has nothing to disclose. Conflict of interest: S.S. Pullamsetti has nothing to disclose. Conflict of interest: R.T. Schermuly has nothing to disclose. Conflict of interest: K.R. Stenmark reports grants from ContraFect, personal fees for advisory board work from Pfizer, New York, personal fees for membership of a steering Committee Member (Entelligence Awards Program) from Actelion, and personal fees for scientific advisory board work from Janssen Research and Development, outside the submitted work. Conflict of interest: M. Rabinovitch reports use of FK506 for the treatment of PAH. The Board of Trustees of Leland Stanford Junior University, assignee. Patent PCT/US2012035793.
Références
Proc Am Thorac Soc. 2006 Sep;3(7):571-6
pubmed: 16963536
Circulation. 2012 May 1;125(17):2128-37
pubmed: 22451584
Eur Respir J. 2013 Jan;41(1):85-95
pubmed: 22523355
Cardiovasc Res. 2013 Dec 1;100(3):354-62
pubmed: 23867631
N Engl J Med. 2013 Jul 25;369(4):351-361
pubmed: 23883380
Am J Respir Crit Care Med. 2014 Feb 1;189(3):314-24
pubmed: 24251580
Circulation. 2014 Feb 18;129(7):786-97
pubmed: 24270264
Am J Respir Cell Mol Biol. 2014 Jun;50(6):1118-28
pubmed: 24433082
J Exp Med. 2014 Feb 10;211(2):263-80
pubmed: 24446489
Circulation. 2014 Apr 15;129(15):1586-97
pubmed: 24481949
Eur Respir J. 2014 Nov;44(5):1275-88
pubmed: 25142477
Cell Metab. 2014 Nov 4;20(5):827-839
pubmed: 25284742
Nat Med. 2014 Nov;20(11):1289-300
pubmed: 25344740
Chest. 2015 Jun;147(6):1610-1620
pubmed: 25429518
Am J Pathol. 2015 Jan;185(1):69-84
pubmed: 25447046
Circulation. 2015 Mar 17;131(11):1006-18
pubmed: 25593290
Am J Physiol Cell Physiol. 2015 Apr 15;308(8):C581-93
pubmed: 25673771
Eur Respir J. 2015 Apr;45(4):1066-80
pubmed: 25745038
Cell Metab. 2015 Apr 7;21(4):596-608
pubmed: 25863249
Proc Natl Acad Sci U S A. 2015 May 19;112(20):E2677-86
pubmed: 25941359
Am J Respir Crit Care Med. 2015 Aug 1;192(3):356-66
pubmed: 26030479
Am J Respir Crit Care Med. 2015 Oct 1;192(7):859-72
pubmed: 26073741
Am J Physiol Cell Physiol. 2015 Sep 15;309(6):C363-72
pubmed: 26084306
Am J Respir Crit Care Med. 2015 Oct 15;192(8):983-97
pubmed: 26203495
Nature. 2015 Aug 20;524(7565):356-60
pubmed: 26258299
J Int Med Res. 2015 Oct;43(5):661-71
pubmed: 26347546
Hypertension. 2015 Dec;66(6):1227-1239
pubmed: 26558820
Am J Respir Crit Care Med. 2016 Apr 15;193(8):898-909
pubmed: 26651104
J Cell Sci. 2016 Feb 15;129(4):693-705
pubmed: 26743080
Am J Respir Crit Care Med. 2016 Jun 15;193(12):1410-20
pubmed: 26760925
Circ Res. 2016 Mar 4;118(5):822-33
pubmed: 26838788
Circulation. 2016 Apr 5;133(14):1371-85
pubmed: 26912814
Am J Respir Crit Care Med. 2016 Mar 1;193(5):574-6
pubmed: 26930433
Mol Cell Biol. 2016 May 02;36(10):1584-94
pubmed: 26976644
Cardiovasc Res. 2016 Jun 1;110(3):319-30
pubmed: 26980205
Eur Respir J. 2016 May;47(5):1518-34
pubmed: 27009171
Cardiovasc Res. 2016 Jul 1;111(1):16-25
pubmed: 27037259
Circulation. 2016 May 3;133(18):1734-7
pubmed: 27045137
Circulation. 2016 May 3;133(18):1783-94
pubmed: 27045138
Am J Respir Crit Care Med. 2016 Nov 1;194(9):1140-1151
pubmed: 27115515
Am J Respir Crit Care Med. 2016 Oct 1;194(7):866-877
pubmed: 27119551
Circulation. 2016 Jun 14;133(24):2447-58
pubmed: 27143681
Am J Respir Crit Care Med. 2016 Nov 15;194(10):1273-1285
pubmed: 27149112
Am J Respir Cell Mol Biol. 2016 Oct;55(4):564-575
pubmed: 27187737
Am J Physiol Lung Cell Mol Physiol. 2016 Aug 1;311(2):L238-54
pubmed: 27317687
Int J Mol Sci. 2016 Jun 22;17(6):
pubmed: 27338373
Eur Respir J. 2016 Aug;48(2):470-83
pubmed: 27418552
Arterioscler Thromb Vasc Biol. 2016 Oct;36(10):2078-87
pubmed: 27470511
J Clin Invest. 2016 Sep 1;126(9):3207-18
pubmed: 27482885
Eur Respir J. 2016 Oct;48(4):1127-1136
pubmed: 27540020
J Clin Invest. 2016 Sep 1;126(9):3313-35
pubmed: 27548520
Circulation. 2016 Oct 11;134(15):1105-1121
pubmed: 27562971
Am J Respir Crit Care Med. 2017 Feb 15;195(4):515-529
pubmed: 27648837
Am J Respir Crit Care Med. 2017 Mar 1;195(5):583-595
pubmed: 27649290
Pulm Circ. 2016 Sep;6(3):347-59
pubmed: 27683612
Am J Respir Crit Care Med. 2017 Apr 1;195(7):930-941
pubmed: 27779452
Eur Respir J. 2016 Dec;48(6):1668-1681
pubmed: 27811071
Am J Physiol Lung Cell Mol Physiol. 2017 Mar 1;312(3):L309-L325
pubmed: 27979859
Cell Stem Cell. 2017 Apr 6;20(4):490-504.e5
pubmed: 28017794
J Ocul Pharmacol Ther. 2017 Apr;33(3):186-192
pubmed: 28072560
Nat Commun. 2017 Jan 13;8:14079
pubmed: 28084316
JCI Insight. 2017 Jan 26;2(2):e90427
pubmed: 28138562
Circulation. 2017 Jun 6;135(23):2288-2298
pubmed: 28356442
Cardiovasc Res. 2017 May 1;113(6):586-597
pubmed: 28407046
BMC Pulm Med. 2017 Apr 26;17(1):72
pubmed: 28446163
Cell Metab. 2017 May 2;25(5):1118-1134.e7
pubmed: 28467929
J Immunol. 2017 Jun 15;198(12):4802-4812
pubmed: 28500078
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1559-1569
pubmed: 28619995
Sci Rep. 2017 Jul 3;7(1):4546
pubmed: 28674407
Circulation. 2017 Nov 14;136(20):1920-1935
pubmed: 28935667
Circulation. 2017 Dec 19;136(25):2451-2467
pubmed: 28971999
Circulation. 2017 Dec 19;136(25):2468-2485
pubmed: 28972001
Stem Cell Res Ther. 2017 Oct 3;8(1):220
pubmed: 28974252
Sci Transl Med. 2017 Oct 25;9(413):null
pubmed: 29070699
Am J Respir Crit Care Med. 2018 Jan 15;197(2):244-260
pubmed: 29095649
Am J Respir Cell Mol Biol. 2018 May;58(5):658-667
pubmed: 29100477
J Heart Lung Transplant. 2018 May;37(5):647-655
pubmed: 29108819
Sci Transl Med. 2017 Nov 15;9(416):null
pubmed: 29141888
Circulation. 2018 Apr 24;137(17):1796-1810
pubmed: 29246894
J Mol Med (Berl). 2018 Feb;96(2):223-235
pubmed: 29290032
Eur Respir J. 2018 Mar 1;51(3):
pubmed: 29348153
Hypertension. 2018 Mar;71(3):518-529
pubmed: 29358461
Cardiovasc Res. 2018 May 1;114(6):880-893
pubmed: 29360952
Am J Respir Crit Care Med. 2018 Jul 1;198(1):90-103
pubmed: 29394093
Eur Respir J. 2018 Apr 4;51(4):
pubmed: 29545281
Circ Res. 2018 Mar 30;122(7):1021-1032
pubmed: 29599278
J Clin Invest. 2018 May 1;128(5):1956-1970
pubmed: 29629897
Eur Respir J. 2018 May 17;51(5):
pubmed: 29773606